Display options
Cite
Ribeiro ST, Barata JT, Silva-Santos B. Multifaceted CK2 in malignant and healthy T cells. Oncotarget. 2017;8(53):90622-90623doi: 10.18632/oncotarget.21700.
Ribeiro, S. T., Barata, J. T., & Silva-Santos, B. (2017). Multifaceted CK2 in malignant and healthy T cells. Oncotarget, 8(53), 90622-90623. https://doi.org/10.18632/oncotarget.21700
Ribeiro, Sérgio T, et al. "Multifaceted CK2 in malignant and healthy T cells." Oncotarget vol. 8,53 (2017): 90622-90623. doi: https://doi.org/10.18632/oncotarget.21700
Ribeiro ST, Barata JT, Silva-Santos B. Multifaceted CK2 in malignant and healthy T cells. Oncotarget. 2017 Oct 09;8(53):90622-90623. doi: 10.18632/oncotarget.21700. eCollection 2017 Oct 31. PMID: 29207585; PMCID: PMC5710866.
Copy Download .nbib Format: NLM
Share it on

Oncotarget. 2017 Oct 09;8(53):90622-90623. doi: 10.18632/oncotarget.21700. eCollection 2017 Oct 31.

Multifaceted CK2 in malignant and healthy T cells.

Oncotarget

Sérgio T Ribeiro, João T Barata, Bruno Silva-Santos

Affiliations

  1. Bruno Silva-Santos: Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.

PMID: 29207585 PMCID: PMC5710866 DOI: 10.18632/oncotarget.21700

[No abstract available.]

Keywords: T-cell acute lymphoblastic leukemia; protein kinase CK2; γδ T lymphocytes

References

  1. Nat Immunol. 2015 Mar;16(3):267-75 - PubMed
  2. Nat Rev Immunol. 2015 Nov;15(11):683-91 - PubMed
  3. Leukemia. 2014 Mar;28(3):543-53 - PubMed
  4. Haematologica. 2005 Feb;90(2):264-6 - PubMed
  5. J Immunol. 2012 Sep 15;189(6):2918-30 - PubMed
  6. Leukemia. 2017 Jul;31(7):1603-1610 - PubMed
  7. J Clin Invest. 2008 Nov;118(11):3762-74 - PubMed
  8. Haematologica. 2016 Nov;101(11):1368-1379 - PubMed

Publication Types